Evoke Pharma (EVOK) underscores its commitment to patients and healthcare providers managing gastroparesis in light of FDA’s recent update regarding domperidone supply. As the sole FDA-approved nasal ...
Evoke Pharma, Inc. announces its commitment to addressing the needs of patients with gastroparesis following the FDA's update indicating that the supply of unapproved domperidone, used internationally ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback